Literature DB >> 29729587

Assessing sudomotor impairment in patients with peripheral neuropathy: Comparison between electrochemical skin conductance and skin biopsy.

Mathilde Duchesne1, Laurence Richard2, Jean-Michel Vallat2, Laurent Magy2.   

Abstract

OBJECTIVE: Sudoscan provides a rapid assessment of sudomotor function based on the measurement of electrochemical skin conductance (ESC), which is thought to be proportional to small nerve fibres innervating the sweat glands. However, the relationship between ESC and small nerve fibre density on skin biopsy remains unclear.
METHODS: In a retrospective single-centre study, we compared ESC measurements with autonomic sweat gland nerve fibre density (SGNFD) and somatic intraepidermal nerve fibre density (IENFD) in patients with polyneuropathy.
RESULTS: 63 patients were included (mean age: 60.6 ± 13.3 years). ESC was more strongly correlated with SGNFD (r = 0.49; p = 0.0005) than with IENFD (r = 0.42; p = 0.0005). Foot ESC was lower in patients with abnormal SGNFD (1.0 ± 0.3 µS/kg versus 0.7 ± 0.4 µS/kg; p = 0.0419) or abnormal IENFD (1.1 ± 0.3 µS/kg versus 0.8 ± 0.3 µS/kg; p = 0.0425).
CONCLUSION: ESC measurement is a novel method of potential value for assessing sudomotor function. More studies are required to define its place beside ancient well-established techniques. SIGNIFICANCE: The weak correlation of ESC with skin biopsy results suggests that mechanisms other than the loss of innervating fibres may be responsible for sweat gland dysfunction in polyneuropathies.
Copyright © 2018 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dysautonomia; ESC; Neuropathic pain; Skin biopsy; Sudomotor function

Mesh:

Year:  2018        PMID: 29729587     DOI: 10.1016/j.clinph.2018.04.608

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  6 in total

1.  Dysregulation of the NRG1/ERBB pathway causes a developmental disorder with gastrointestinal dysmotility in humans.

Authors:  Thuy-Linh Le; Louise Galmiche; Jonathan Levy; Pim Suwannarat; Debby Mei Hellebrekers; Khomgrit Morarach; Franck Boismoreau; Tom Ej Theunissen; Mathilde Lefebvre; Anna Pelet; Jelena Martinovic; Antoinette Gelot; Fabien Guimiot; Amanda Calleroz; Cyril Gitiaux; Marie Hully; Olivier Goulet; Christophe Chardot; Severine Drunat; Yline Capri; Christine Bole-Feysot; Patrick Nitschké; Sandra Whalen; Linda Mouthon; Holly E Babcock; Robert Hofstra; Irenaeus Fm de Coo; Anne-Claude Tabet; Thierry J Molina; Boris Keren; Alice Brooks; Hubert Jm Smeets; Ulrika Marklund; Christopher T Gordon; Stanislas Lyonnet; Jeanne Amiel; Nadège Bondurand
Journal:  J Clin Invest       Date:  2021-03-15       Impact factor: 14.808

Review 2.  Small Fiber Neuropathy in Diabetes Polyneuropathy: Is It Time to Change?

Authors:  Sanjeev Sharma; Prashanth Vas; Gerry Rayman
Journal:  J Diabetes Sci Technol       Date:  2021-04-12

3.  Insights From Invasive Cardiopulmonary Exercise Testing of Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Authors:  Phillip Joseph; Carlo Arevalo; Rudolf K F Oliveira; Mariana Faria-Urbina; Donna Felsenstein; Anne Louise Oaklander; David M Systrom
Journal:  Chest       Date:  2021-02-10       Impact factor: 10.262

4.  Diagnostic Accuracy of Electrochemical Skin Conductance in the Detection of Sudomotor Fiber Loss.

Authors:  Michal G Porubcin; Peter Novak
Journal:  Front Neurol       Date:  2020-04-17       Impact factor: 4.003

5.  SUDOSCAN in Combination with the Michigan Neuropathy Screening Instrument Is an Effective Tool for Screening Diabetic Peripheral Neuropathy.

Authors:  Tae Jung Oh; Yoojung Song; Hak Chul Jang; Sung Hee Choi
Journal:  Diabetes Metab J       Date:  2021-09-16       Impact factor: 5.376

6.  The Role of Electrochemical Skin Conductance as a Screening Test of Cardiovascular Autonomic Neuropathy in Patients with Parkinson's Disease.

Authors:  Chih-Cheng Huang; Yun-Ru Lai; Chia-Yi Lien; Ben-Chung Cheng; Nai-Wen Tsai; Cheng-Hsien Lu
Journal:  Int J Environ Res Public Health       Date:  2020-10-23       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.